101 related articles for article (PubMed ID: 17187826)
41. Breast cancer cells have lower activating protein 1 transcription factor activity than normal mammary epithelial cells.
Smith LM; Birrer MJ; Stampfer MR; Brown PH
Cancer Res; 1997 Jul; 57(14):3046-54. PubMed ID: 9230221
[TBL] [Abstract][Full Text] [Related]
42. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
[TBL] [Abstract][Full Text] [Related]
43. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition.
Chen H; Zhang H; Lee J; Liang X; Wu X; Zhu T; Lo PK; Zhang X; Sukumar S
Cancer Res; 2007 Sep; 67(17):8007-13. PubMed ID: 17804711
[TBL] [Abstract][Full Text] [Related]
44. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
45. S100A7 (psoriasin) influences immune response genes in human breast cancer.
Mandal S; Curtis L; Pind M; Murphy LC; Watson PH
Exp Cell Res; 2007 Aug; 313(14):3016-25. PubMed ID: 17560571
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
Travaglini L; Vian L; Billi M; Grignani F; Nervi C
Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
[TBL] [Abstract][Full Text] [Related]
47. Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells.
Catalano MG; Costantino L; Frairia R; Boccuzzi G; Fortunati N
Horm Metab Res; 2007 Apr; 39(4):288-94. PubMed ID: 17447168
[TBL] [Abstract][Full Text] [Related]
48. c-myc gene inactivation during induction of nasopharyngeal carcinoma cells with retinoic acid.
Jiang N; Zhan F; Cao L; Yao K; Li G
Chin Med J (Engl); 2000 Sep; 113(9):823-6. PubMed ID: 11776079
[TBL] [Abstract][Full Text] [Related]
49. Metabolic conversion of retinol to retinoic acid mediates the biological responsiveness of human mammary epithelial cells to retinol.
Hayden LJ; Hawk SN; Sih TR; Satre MA
J Cell Physiol; 2001 Mar; 186(3):437-47. PubMed ID: 11169983
[TBL] [Abstract][Full Text] [Related]
50. Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells.
Hammamieh R; Chakraborty N; Miller SA; Waddy E; Barmada M; Das R; Peel SA; Day AA; Jett M
Breast Cancer Res Treat; 2007 Jan; 101(1):7-16. PubMed ID: 16823509
[TBL] [Abstract][Full Text] [Related]
51. Activation of the CRABPII/RAR pathway by curcumin induces retinoic acid mediated apoptosis in retinoic acid resistant breast cancer cells.
Thulasiraman P; Garriga G; Danthuluri V; McAndrews DJ; Mohiuddin IQ
Oncol Rep; 2017 Apr; 37(4):2007-2015. PubMed ID: 28350049
[TBL] [Abstract][Full Text] [Related]
52. AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs.
McPherson LA; Weigel RJ
Nucleic Acids Res; 1999 Oct; 27(20):4040-9. PubMed ID: 10497269
[TBL] [Abstract][Full Text] [Related]
53. Identification of genes with altered expression in medullary breast cancer vs. ductal breast cancer and normal breast epithelia.
Gjerstorff MF; Benoit VM; Laenkholm AV; Nielsen O; Johansen LE; Ditzel HJ
Int J Oncol; 2006 Jun; 28(6):1327-35. PubMed ID: 16685433
[TBL] [Abstract][Full Text] [Related]
54. Transcription factor AP2-Sp and its target genes in malarial sporozoites.
Yuda M; Iwanaga S; Shigenobu S; Kato T; Kaneko I
Mol Microbiol; 2010 Feb; 75(4):854-63. PubMed ID: 20025671
[TBL] [Abstract][Full Text] [Related]
55. A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: implications for predicting breast cancer risk.
Bistulfi G; Pozzi S; Ren M; Rossetti S; Sacchi N
Cancer Res; 2006 Nov; 66(21):10308-14. PubMed ID: 17079450
[TBL] [Abstract][Full Text] [Related]
56. Genomic structure of the promoters of the human estrogen receptor-alpha gene demonstrate changes in chromatin structure induced by AP2gamma.
Schuur ER; McPherson LA; Yang GP; Weigel RJ
J Biol Chem; 2001 May; 276(18):15519-26. PubMed ID: 11278455
[TBL] [Abstract][Full Text] [Related]
57. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
58. Identification of ERF-1 as a member of the AP2 transcription factor family.
McPherson LA; Baichwal VR; Weigel RJ
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4342-7. PubMed ID: 9113991
[TBL] [Abstract][Full Text] [Related]
59. Functional and chromosomal clustering of genes responsive to 5-bromodeoxyuridine in human cells.
Minagawa S; Nakabayashi K; Fujii M; Scherer SW; Ayusawa D
Exp Gerontol; 2004 Jul; 39(7):1069-78. PubMed ID: 15236766
[TBL] [Abstract][Full Text] [Related]
60. The structure of Apo-wild-type cellular retinoic acid binding protein II at 1.4 A and its relationship to ligand binding and nuclear translocation.
Vaezeslami S; Mathes E; Vasileiou C; Borhan B; Geiger JH
J Mol Biol; 2006 Oct; 363(3):687-701. PubMed ID: 16979656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
